Global Opioids Drug Sales Market Report 2024
The global Opioids Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Opioids Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Oxycodone
Hydromorphone
Codeine
Fentanyl
Others
Segment by Application
Pain Relief
Anesthesia
Others
The Opioids Drug market is analysed and market size information is provided by regions (countries).
Segment by Application
, the Opioids Drug market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Teva
Purdue Pharma
Mallinckrodt
Amneal Pharma
Collegium
J&J
Endo
Pfizer
INSYS
Mylan
Hikma
Egalet

Table of Content
1 Opioids Drug Market Overview
1.1 Opioids Drug Product Scope
1.2 Opioids Drug Segment by Type
1.2.1 Global Opioids Drug Sales by Type (2016 & 2021 & 2027)
1.2.2 Oxycodone
1.2.3 Hydromorphone
1.2.4 Codeine
1.2.5 Fentanyl
1.2.6 Others
1.3 Opioids Drug Segment by Application
1.3.1 Global Opioids Drug Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Pain Relief
1.3.3 Anesthesia
1.3.4 Others
1.4 Opioids Drug Market Estimates and Forecasts (2016-2027)
1.4.1 Global Opioids Drug Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Opioids Drug Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Opioids Drug Price Trends (2016-2027)
2 Opioids Drug Estimates and Forecasts by Region
2.1 Global Opioids Drug Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Opioids Drug Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Opioids Drug Sales Market Share by Region (2016-2021)
2.2.2 Global Opioids Drug Revenue Market Share by Region (2016-2021)
2.3 Global Opioids Drug Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Opioids Drug Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Opioids Drug Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Opioids Drug Estimates and Projections (2016-2027)
2.4.2 Europe Opioids Drug Estimates and Projections (2016-2027)
2.4.3 China Opioids Drug Estimates and Projections (2016-2027)
2.4.4 Japan Opioids Drug Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Opioids Drug Estimates and Projections (2016-2027)
2.4.6 India Opioids Drug Estimates and Projections (2016-2027)
3 Global Opioids Drug Competition Landscape by Players
3.1 Global Top Opioids Drug Players by Sales (2016-2021)
3.2 Global Top Opioids Drug Players by Revenue (2016-2021)
3.3 Global Opioids Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Opioids Drug as of 2020)
3.4 Global Opioids Drug Average Price by Company (2016-2021)
3.5 Manufacturers Opioids Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Opioids Drug Market Size by Type
4.1 Global Opioids Drug Historic Market Review by Type (2016-2021)
4.1.1 Global Opioids Drug Sales Market Share by Type (2016-2021)
4.1.2 Global Opioids Drug Revenue Market Share by Type (2016-2021)
4.1.3 Global Opioids Drug Price by Type (2016-2021)
4.2 Global Opioids Drug Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Opioids Drug Sales Forecast by Type (2022-2027)
4.2.2 Global Opioids Drug Revenue Forecast by Type (2022-2027)
4.2.3 Global Opioids Drug Price Forecast by Type (2022-2027)
5 Global Opioids Drug Market Size by Application
5.1 Global Opioids Drug Historic Market Review by Application (2016-2021)
5.1.1 Global Opioids Drug Sales Market Share by Application (2016-2021)
5.1.2 Global Opioids Drug Revenue Market Share by Application (2016-2021)
5.1.3 Global Opioids Drug Price by Application (2016-2021)
5.2 Global Opioids Drug Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Opioids Drug Sales Forecast by Application (2022-2027)
5.2.2 Global Opioids Drug Revenue Forecast by Application (2022-2027)
5.2.3 Global Opioids Drug Price Forecast by Application (2022-2027)
6 North America Opioids Drug Market Facts & Figures
6.1 North America Opioids Drug Sales by Company
6.1.1 North America Opioids Drug Sales by Company (2016-2021)
6.1.2 North America Opioids Drug Revenue by Company (2016-2021)
6.2 North America Opioids Drug Sales Breakdown by Type
6.2.1 North America Opioids Drug Sales Breakdown by Type (2016-2021)
6.2.2 North America Opioids Drug Sales Breakdown by Type (2022-2027)
6.3 North America Opioids Drug Sales Breakdown by Application
6.3.1 North America Opioids Drug Sales Breakdown by Application (2016-2021)
6.3.2 North America Opioids Drug Sales Breakdown by Application (2022-2027)
7 Europe Opioids Drug Market Facts & Figures
7.1 Europe Opioids Drug Sales by Company
7.1.1 Europe Opioids Drug Sales by Company (2016-2021)
7.1.2 Europe Opioids Drug Revenue by Company (2016-2021)
7.2 Europe Opioids Drug Sales Breakdown by Type
7.2.1 Europe Opioids Drug Sales Breakdown by Type (2016-2021)
7.2.2 Europe Opioids Drug Sales Breakdown by Type (2022-2027)
7.3 Europe Opioids Drug Sales Breakdown by Application
7.3.1 Europe 145 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 145 Sales Breakdown by Application (2022-2027)
8 China Opioids Drug Market Facts & Figures
8.1 China Opioids Drug Sales by Company
8.1.1 China Opioids Drug Sales by Company (2016-2021)
8.1.2 China Opioids Drug Revenue by Company (2016-2021)
8.2 China Opioids Drug Sales Breakdown by Type
8.2.1 China Opioids Drug Sales Breakdown by Type (2016-2021)
8.2.2 China Opioids Drug Sales Breakdown by Type (2022-2027)
8.3 China Opioids Drug Sales Breakdown by Application
8.3.1 China 314 Sales Breakdown by Application (2016-2021)
8.3.2 China 314 Sales Breakdown by Application (2022-2027)
9 Japan Opioids Drug Market Facts & Figures
9.1 Japan Opioids Drug Sales by Company
9.1.1 Japan Opioids Drug Sales by Company (2016-2021)
9.1.2 Japan Opioids Drug Revenue by Company (2016-2021)
9.2 Japan Opioids Drug Sales Breakdown by Type
9.2.1 Japan Opioids Drug Sales Breakdown by Type (2016-2021)
9.2.2 Japan Opioids Drug Sales Breakdown by Type (2022-2027)
9.3 Japan Opioids Drug Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Opioids Drug Market Facts & Figures
10.1 Southeast Asia Opioids Drug Sales by Company
10.1.1 Southeast Asia Opioids Drug Sales by Company (2016-2021)
10.1.2 Southeast Asia Opioids Drug Revenue by Company (2016-2021)
10.2 Southeast Asia Opioids Drug Sales Breakdown by Type
10.2.1 Southeast Asia Opioids Drug Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Opioids Drug Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Opioids Drug Sales Breakdown by Application
10.3.1 Southeast Asia M Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia M Units Sales Breakdown by Application (2022-2027)
11 India Opioids Drug Market Facts & Figures
11.1 India Opioids Drug Sales by Company
11.1.1 India Opioids Drug Sales by Company (2016-2021)
11.1.2 India Opioids Drug Revenue by Company (2016-2021)
11.2 India Opioids Drug Sales Breakdown by Type
11.2.1 India Opioids Drug Sales Breakdown by Type (2016-2021)
11.2.2 India Opioids Drug Sales Breakdown by Type (2022-2027)
11.3 India Opioids Drug Sales Breakdown by Application
11.3.1 India Opioids Drug Sales Breakdown by Application (2016-2021)
11.3.2 India Opioids Drug Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Opioids Drug Business
12.1 Teva
12.1.1 Teva Corporation Information
12.1.2 Teva Business Overview
12.1.3 Teva Opioids Drug Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Teva Opioids Drug Products Offered
12.1.5 Teva Recent Development
12.2 Purdue Pharma
12.2.1 Purdue Pharma Corporation Information
12.2.2 Purdue Pharma Business Overview
12.2.3 Purdue Pharma Opioids Drug Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Purdue Pharma Opioids Drug Products Offered
12.2.5 Purdue Pharma Recent Development
12.3 Mallinckrodt
12.3.1 Mallinckrodt Corporation Information
12.3.2 Mallinckrodt Business Overview
12.3.3 Mallinckrodt Opioids Drug Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Mallinckrodt Opioids Drug Products Offered
12.3.5 Mallinckrodt Recent Development
12.4 Amneal Pharma
12.4.1 Amneal Pharma Corporation Information
12.4.2 Amneal Pharma Business Overview
12.4.3 Amneal Pharma Opioids Drug Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Amneal Pharma Opioids Drug Products Offered
12.4.5 Amneal Pharma Recent Development
12.5 Collegium
12.5.1 Collegium Corporation Information
12.5.2 Collegium Business Overview
12.5.3 Collegium Opioids Drug Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Collegium Opioids Drug Products Offered
12.5.5 Collegium Recent Development
12.6 J&J
12.6.1 J&J Corporation Information
12.6.2 J&J Business Overview
12.6.3 J&J Opioids Drug Sales, Revenue and Gross Margin (2016-2021)
12.6.4 J&J Opioids Drug Products Offered
12.6.5 J&J Recent Development
12.7 Endo
12.7.1 Endo Corporation Information
12.7.2 Endo Business Overview
12.7.3 Endo Opioids Drug Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Endo Opioids Drug Products Offered
12.7.5 Endo Recent Development
12.8 Pfizer
12.8.1 Pfizer Corporation Information
12.8.2 Pfizer Business Overview
12.8.3 Pfizer Opioids Drug Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Pfizer Opioids Drug Products Offered
12.8.5 Pfizer Recent Development
12.9 INSYS
12.9.1 INSYS Corporation Information
12.9.2 INSYS Business Overview
12.9.3 INSYS Opioids Drug Sales, Revenue and Gross Margin (2016-2021)
12.9.4 INSYS Opioids Drug Products Offered
12.9.5 INSYS Recent Development
12.10 Mylan
12.10.1 Mylan Corporation Information
12.10.2 Mylan Business Overview
12.10.3 Mylan Opioids Drug Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Mylan Opioids Drug Products Offered
12.10.5 Mylan Recent Development
12.11 Hikma
12.11.1 Hikma Corporation Information
12.11.2 Hikma Business Overview
12.11.3 Hikma Opioids Drug Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Hikma Opioids Drug Products Offered
12.11.5 Hikma Recent Development
12.12 Egalet
12.12.1 Egalet Corporation Information
12.12.2 Egalet Business Overview
12.12.3 Egalet Opioids Drug Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Egalet Opioids Drug Products Offered
12.12.5 Egalet Recent Development
13 Opioids Drug Manufacturing Cost Analysis
13.1 Opioids Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Opioids Drug
13.4 Opioids Drug Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Opioids Drug Distributors List
14.3 Opioids Drug Customers
15 Market Dynamics
15.1 Opioids Drug Market Trends
15.2 Opioids Drug Drivers
15.3 Opioids Drug Market Challenges
15.4 Opioids Drug Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer